Eun Ji Lee

Ms. Eun Ji Lee

Ulsan University Hospital, Ulsan University College of Medicine
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 October 2021 in Cells
Verified
Journal Article
Open access
PDF file
JJJaeyun Jung
Jaeyun Jung
HRHyun Jin Ryu
Hyun Jin Ryu
SLSeung-Hwan Lee
Seung-Hwan Lee
DKDong-Young Kim
Dong-Young Kim
MKMyung Ji Kim
Myung Ji Kim
Suhwan ChangSuhwan Chang
Suhwan Chang
Pancreatic cancer is characterized by late detection, frequent drug resistance, and a highly metastatic nature, leading to poor prognosis. Antibody-based immunotherapy showed limited success for pancreatic cancer, partly owing to the low delivery rate of the drug into the tumor. Herein, we describe a poly(lactic-co-glycolic acid;PLGA)-based siRNA nanoparticle targeting PD-L1 (siPD-L1@PLGA). The siPD-L1@PLGA exhibited efficient knockdown of PD-L1 in cancer cells, without affecting the cell viability up to 6 mg/mL. Further, 99.2% of PDAC cells uptake the nanoparticle and successfully blocked the IFN-gamma-mediated PD-L1 induction. Consistently, the siPD-L1@PLGA sensitized cancer cells to antigen-specific immune cells, as exemplified by Ovalbumin-targeting T cells. To evaluate its efficacy in vivo, we adopted a pancreatic PDX model in humanized mice, generated by grafting CD34+ hematopoeitic stem cells onto NSG mice. The siPD-L1@PLGA significantly suppressed pancreatic tumor growth in this model with upregulated IFN-gamma positive CD8 T cells, leading to more apoptotic tumor cells. Multiplex immunofluorescence analysis exhibited comparable immune cell compositions in control and siPD-L1@PLGA-treated tumors. However, we found higher Granzyme B expression in the siPD-L1@PLGA-treated tumors, suggesting higher activity of NK or cytotoxic T cells. Based on these results, we propose the application of siPD-L1@PLGA as an immunotherapeutic agent for pancreatic cancer.

16 March 2023 in Molecules and Cells
Verified
Journal Article
Open access
PDF file
MPMin Ji Park
Min Ji Park
EJEunji Jeong
Eunji Jeong
ELEun Ji Lee
Eun Ji Lee
HCHyeon Ji Choi
Hyeon Ji Choi
BMBo Hyun Moon
Bo Hyun Moon
Suhwan ChangSuhwan Chang
Suhwan Chang
Min Ji Park, Eunji Jeong, Eun Ji Lee, Hyeon Ji Choi, Bo Hyun Moon, Keunsoo Kang, and Suhwan Chang. Mol. Cells 2023;46:351-9. https://doi.org/10.14348/molcells.2023.2174

Verified
Journal Article
Open access
PDF file
YSYeon Ah SEO
Yeon Ah SEO
MCMin Jeong Cha
Min Jeong Cha
SPSehyeon Park
Sehyeon Park
SLSeungki Lee
Seungki Lee
YLYe Jin Lim
Ye Jin Lim
Suhwan ChangSuhwan Chang
Suhwan Chang
A key element for the cost-effective development of cultured meat is a cell line culturable in serum-free conditions to reduce production costs. Heme supplementation in cultured meat mimics the original meat flavor and color. This study introduced a bacterial extract generated from Corynebacterium that was selected for high-heme expression by directed evolution. A normal porcine cell line, PK15, was used to apply the bacterial heme extract as a supplement. Consistent with prior research, we observed the cytotoxicity of PK15 to the heme extract at 10 mM or higher. However, after long-term exposure, PK15 adapted to tolerate up to 40 mM of heme. An RNA-seq analysis of these heme-adapted PK15 cells (PK15H) revealed a set of altered genes, mainly involved in cell proliferation, metabolism, and inflammation. We found that cytochrome P450, family 1, subfamily A, polypeptide 1 (CYP1A1), lactoperoxidase (LPO), and glutathione peroxidase 5 (GPX5) were upregulated in the PK15H heme dose dependently. When we reduced serum serially from 2% to serum free, we derived the PK15H subpopulation that was transiently maintained with 5–10 mM heme extract. Altogether, our study reports a porcine cell culturable in high-heme media that can be maintained in serum-free conditions and proposes a marker gene that plays a critical role in this adaptation process.

5 December 2025 in Science Advances
Verified
Journal Article
Open access
JKJeong Yeon Kim
Jeong Yeon Kim
JAJinhyeon An
Jinhyeon An
SKSoyeon Kim
Soyeon Kim
HJHye-Yeong Jo
Hye-Yeong Jo
ELEun Ji Lee
Eun Ji Lee
JCJung Kyoon Choi
Jung Kyoon Choi
B cell involvement in neoantigen-driven antitumor immunity remains largely unexplored because of challenges in predicting B cell responses. Here, we developed a method to identify B cell epitopes by characterizing >437,000 peptides tested for IgG binding and >370 million B cell receptor (BCR) clones. Our single-cell BCR sequencing of pre– and post–severe acute respiratory syndrome coronavirus 2 vaccination validates the performance of this method. Mouse vaccination experiments demonstrate that B cell neoepitopes enhance immune responses, driving BCR expansion and tumor regression. Genomic analysis of >8000 The Cancer Genome Atlas (TCGA) samples reveals an inverse correlation between predicted B cell reactivity and mutation allele frequencies, indicating B cell–mediated neoantigen elimination. Applying our multiomics model to checkpoint blockade responses in 2074 patients highlights the clinical relevance of B cell neoepitope prediction. A meta-analysis of 11 personalized vaccine trials involving 1739 neoantigens suggests that incorporating B cell neoepitopes may improve vaccination efficacy. These results underscore the significance of B cell–reactive neoantigens in antitumor immunity.

17 December 2025 in Foods
Verified
Journal Article
Open access
PDF file
YOYun Ok Oh
Yun Ok Oh
CYChae Won Yu
Chae Won Yu
MCMin Jeong Cha
Min Jeong Cha
ELEun Ji Lee
Eun Ji Lee
PKPil Kim
Pil Kim
Suhwan ChangSuhwan Chang
Suhwan Chang
One of the critical requirements for the production of artificial meat is to mimic the flavor of the original meat. Therefore, incorporation of heme has been proposed, but it is toxic when added at high concentrations in cell culture systems. Additionally, obtaining heme can be costly depending on the source. In this study, we aimed to support the growth of normal bovine muscle cells (BRMC-F2401, BRMCs) by introducing a bacterial extract obtained from a safe, high-heme-containing Corynebacterium species. The BRMCs exhibited heme toxicity when the bacterial heme level was >20 μM; however, they were adapted to stably proliferate with a 3 on–3 off culture scheme. RNA sequencing of the heme-adapted BRMCs showed gene expression changes, including upregulation of detoxification genes, CYP1A1, CYP26B1, and SERPINB2. The knockdown of these three genes increased heme sensitivity and reversed heme tolerance of the heme-adapted BRMCs. Additionally, ROS levels increased upon heme treatment, suggesting that ROS is an important factor in heme adaptation processes. Collectively, our study presents an affordable strategy to incorporate heme in cultured meat production and the mechanism underlying this process.